Summary: A new study has clarified the limits of lifestyle interventions in preventing cognitive decline across different genetic profiles. The research evaluated how modifiable risk factors (mRF), such as physical activity and blood pressure control, interact with the APOE ε4 genotype, a primary genetic driver of Alzheimer’s disease.
The findings demonstrate that while a healthy lifestyle significantly lowers dementia risk and reduces structural brain damage in individuals with one or zero APOE ε4 alleles, it provides no measurable protection for homozygous carriers who inherit two copies of the risk gene.
Key Facts
- The Demographic Baseline: Researchers analyzed a cohort of 9,605 community-dwelling Japanese adults aged 65 and older to evaluate the joint impact of genetic predisposition and modifiable lifestyle choices.
- The 10-Fold Homozygote Risk: Dementia risk increased progressively with the number of inherited APOE ε4 alleles. Individuals inheriting two copies of the allele (homozygotes) exhibited a greater than 10-fold increase in dementia risk compared to noncarriers.
- The Lifestyle Benefit Limit: For participants carrying one or zero APOE ε4 alleles, lower modifiable risk factor (mRF) scores, reflecting healthier lifestyle behaviors, correlated with a significantly lower risk of dementia.
- The Homozygous Insulated Risk: Among individuals carrying two APOE ε4 alleles, dementia risk remained statistically identical regardless of whether the person maintained a highly favorable or unfavorable lifestyle profile.
- MRI Neuroimaging Confirmation: Brain scans tracked the structural correlates of the statistical findings:
- One or Zero Alleles: Healthier lifestyles were linked to less overall brain atrophy and fewer white matter lesions (damaged brain tissue tied to cognitive decline).
- Two Alleles: Subjects exhibited advanced brain atrophy and extensive white matter lesions regardless of their underlying health habits.
- The 2050 Global Prevention Pivot: With worldwide dementia cases expected to triple by 2050, identifying precise genetic boundaries helps transition public health away from blanket advice and toward targeted intervention.
- Clinical Horizon Shift: Lead investigator Professor Toshiharu Ninomiya notes that while managing vascular and lifestyle risk factors is highly effective for single-allele carriers, double-allele carriers require early pharmaceutical, therapeutic, or novel preventative approaches beyond standard health habits.
Source: Kyushu University
With dementia cases expected to nearly triple worldwide by 2050, researchers are increasingly focused on identifying ways to prevent or delay the disease. While lifestyle and health-related factors, such as blood pressure control and physical activity, influence dementia risk, genetics also play a major role.
Currently, it is unclear if maintaining a favorable lifestyle reduces dementia risk equally across different genetic backgrounds.
A new study led by Kyushu University and RIKEN, published on May 21 in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, examines whether favorable modifiable risk factors (mRF)—behaviors or conditions that people can change or control—can lower dementia risk even among individuals with high genetic susceptibility.
To explore this, the researchers analyzed data from 9,605 community-dwelling Japanese adults aged 65 and older. They determined each participant’s APOE ε4 genotypes, a primary genetic risk factor for Alzheimer’s disease, and calculated the mRF score based on lifestyle and health-related factors. This allowed the team to evaluate how genetic predisposition and lifestyle choices jointly interact to influence dementia risk.
The results showed that dementia risk rose progressively with the number of APOE ε4 alleles. Since humans inherit one allele of each gene from each parent, a person can carry zero, one, or two APOE ε4 alleles. Individuals carrying two alleles, known as homozygotes, had over 10-fold higher dementia risk than noncarriers.
Notably, among individuals with one or no APOE ε4 alleles, maintaining a healthier profile with lower mRF scores was linked to a significantly lower risk of dementia. In contrast, among individuals with two APOE ε4 alleles, dementia risk did not differ significantly between those with lower and higher mRF scores.
Brain MRI scans supported these findings. Among those with one or no alleles of the gene, lower mRF scores were associated with less brain atrophy and fewer white matter lesions—areas of damaged tissue in the brain that are linked to cognitive decline and dementia. In contrast, individuals with two alleles of the gene exhibited greater brain atrophy and more extensive tissue damage regardless of their lifestyle profile.
These findings suggest that maintaining favorable lifestyle and health conditions can effectively mitigate dementia risk, even among individuals carrying a single APOE ε4 allele. This underscores the importance of population-based prevention strategies focused on managing vascular and lifestyle risk factors.
“Among individuals carrying one APOE ε4 allele, as in those carrying no APOE ε4 alleles, favorable management of risk factors may help reduce the risk of dementia,” says Professor Toshiharu Ninomiya from Kyushu University’s Faculty of Medical Sciences, who led the study.
“On the other hand, for individuals carrying two APOE ε4 alleles, earlier intervention as well as new preventive or therapeutic approaches beyond lifestyle and health management may warrant consideration.”
Key Questions Answered:
A: No. The Kyushu University study proved that for people carrying two copies of the APOE ε4 gene, maintaining a healthy lifestyle did not lower their risk of dementia or protect their brains from tissue damage compared to those with unhealthy habits.
A: Lifestyle choices still matter for single-allele carriers. Individuals with just one APOE ε4 allele experience a significant reduction in dementia risk, less brain atrophy, and fewer white matter lesions when they maintain a favorable health profile.
A: Earlier medical screening and next-generation therapies. Because standard health and vascular management cannot bypass the high genetic risk of carrying two alleles, Professor Toshiharu Ninomiya states these individuals require advanced preventive or therapeutic strategies that go beyond basic lifestyle changes.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this genetics and dementia research news
Author: Qinlin Wu
Source: Kyushu University
Contact: Qinlin Wu – Kyushu University
Image: The image is credited to Neuroscience News
Original Research: Closed access.
“APOE ε4, modifiable risk factors and dementia in community-based older Japanese adults” by Masaya Kumamoto, Toshiharu Ninomiya, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Jun Hata, Tetsuro Ago, Yasuyuki Taki, Tatsuya Mikami, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Ritsuko Hanajima, Jun-ichi Iga, Minoru Takebayashi, Yukihide Momozawa, the Japan Prospective Studies for Aging and Dementia (JPSC-AD) Study Group#. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
DOI:10.1002/dad2.70371
Abstract
APOE ε4, modifiable risk factors and dementia in community-based older Japanese adults
INTRODUCTION
Apolipoprotein E (APOE) ε4 is a major genetic risk factor for dementia. We examined whether APOE ε4 genotype modified the associations between a modifiable risk factor (mRF) score and dementia in older Japanese adults.
METHODS
This cross-sectional study included 9605 community-dwelling Japanese individuals aged ≥65 years. APOE ε4 genotype and mRF scores were assessed. Dementia was clinically diagnosed. Brain magnetic resonance imaging (MRI) measures were available in a subset.
RESULTS
The odds ratio (OR) for dementia increased with the number of APOE ε4 alleles. A low mRF score was associated with lower ORs for prevalent dementia in non-carriers and heterozygotes but not in homozygotes. On MRI, low mRF scores were associated with preserved brain structure in non-carriers and heterozygotes, but not in homozygotes.
DISCUSSION
Favorable risk factor profiles were associated with lower dementia risk and preserved brain structure in APOE ε4 non-carriers and heterozygotes, but not in homozygotes, supporting genotype-tailored prevention strategies.
